Evidence map›Paper›PMID 33301229›Full record

ArticleMolecular genetics & genomic medicine2021

Early truncation of the N-terminal variable region of EYA4 gene causes dominant hearing loss without cardiac phenotype.

Yanfang Mi, Danhua Liu, Beiping Zeng, Yongan Tian, Hui Zhang, Bei Chen, Juanli Zhang, Hong Xue, Wenxue Tang, Yulin Zhao and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Molecular genetics & genomic medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Missense Variant of Endoplasmic Reticulum Region ofBioMed research international · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Yanfang MiDepartment of Otorhinolaryngology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Danhua LiuPrecision Medicine Center, Academy of Medical Science, Zhengzhou University, Zhengzhou, China.
Beiping ZengBGI College, Zhengzhou University, Zhengzhou, China.
Yongan TianBGI College, Zhengzhou University, Zhengzhou, China.
Hui ZhangDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Bei ChenDepartment of Otorhinolaryngology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Juanli ZhangHenan Province Medical Instrument Testing Institute, Zhengzhou, China.
Hong XueSanglin Biotechnology Ltd, Zhengzhou, China.
Wenxue TangPrecision Medicine Center, Academy of Medical Science, Zhengzhou University, Zhengzhou, China.
Yulin ZhaoDepartment of Otorhinolaryngology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Hongen XuPrecision Medicine Center, Academy of Medical Science, Zhengzhou University, Zhengzhou, China.ORCID 0000-0001-7895-0899
Zhengzhou University · CNFirst Affiliated Hospital of Zhengzhou University · CNHenan Provincial Institute of Occupational Health · CNSana Biotechnology (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutosomal dominant hearing loss (ADHL) accounts for about 20% of all hereditary non-syndromic HL. Truncating mutations of the EYA4 gene can cause either non-syndromic ADHL or syndromic ADHL with cardiac abnormalities. It has been proposed that truncations of the C-terminal Eya domain lead to non-syndromic HL, whereas early truncations of the N-terminal variable region cause syndromic HL with cardiac phenotype.

methodsThe proband and all the other hearing impaired members of the family underwent a thorough clinical and audiological evaluation. The cardiac phenotype was examined by ECG and echocardiography. Their DNA was subjected to target exome sequencing of 129 known deafness genes. The sequencing data were analyzed and the candidate variants were interpreted following the ACMG guidelines for clinical sequence interpretation. The effect of candidate variant on EYA4 gene expression was assessed by quantitative PCR and western blot of gene production in blood.

resultsWe report a Chinese family cosegregating post-lingual onset, progressive ADHL with a novel nonsense mutation NM_004100.4:c.543C>G (p.Tyr181Ter) of EYA4. Two affected members show no cardiac abnormalities at least until now revealed by electrocardiography and echocardiography. The overall expression level of the EYA4 gene in the proband was lower than that in his unaffected relative.

conclusionThis report expands the mutational spectrum of the EYA4 gene and highlights the fact that more data are needed to elucidate the complex genotype-phenotype correlation of EYA4 mutations.

Indexed as

Codon, NonsensePhenotypeAdultCardiomyopathiesFemaleHearing Loss, SensorineuralHumansMalePedigreeProtein DomainsTrans-ActivatorsCodon, NonsenseEYA4 protein, humanTrans-Activatorsautosomal dominant hearing lossEYA4next-generation sequencing

Identifiers

PMID33301229
PMCPMC7963430
OpenAlexW3112411493

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.